Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 3
Subtitle 10 - LABORATORIES
Chapter 10.10.01 - General
Section 10.10.01.03 - Definitions
Universal Citation: MD Code Reg 10.10.01.03
Current through Register Vol. 51, No. 19, September 20, 2024
A. In this subtitle, the following terms have the meanings indicated.
B. Terms Defined.
(1) Accuracy or Accurate.
(a) "Accuracy" or "accurate" means the degree
of agreement between the determination of a quantity and its true
value.
(b) "Accuracy" or "accurate"
includes the quality of a test result as it relates to the analytic phase of
the testing process when the test result:
(i)
Conforms exactly to a standard; or
(ii) Deviates only within established limits
from a standard.
(2) "Alternative sanction" means a directed
plan of correction or a limitation placed on testing.
(3) "Analyte" means a substance or
constituent for which a laboratory conducts testing.
(4) "Analytical system" means a test system's
methods, procedures, instruments, equipment, kits, reagents, and supporting
materials used to detect or measure an analyte or perform a test.
(5) Authorized Person.
(a) "Authorized person" means an individual
allowed to request a laboratory test.
(b) "Authorized person" is limited to those
individuals identified under COMAR
10.10.06.02C.
(5-1) "Buccal cavity" means the vestibule of the mouth, specifically the area lying between the teeth and cheeks.
(5-2) "Buccal swab" means a specialized applicator with a sponge, cotton, or Dacron tip, used to collect epithelial cells for DNA testing by rubbing the applicator tip on the inside of the cheek in the buccal cavity.
(6)
"Calibrator" means a material having a known value or concentration that is
used to standardize an analytical system.
(7) "CDC" means the Centers for Disease
Control and Prevention.
(8)
"Certified analyst" means an individual who:
(a) Meets the qualifications established
under COMAR
10.10.09.01BB and
.02C; and
(b) Is thereby permitted
to identify marijuana or marijuana products, or both, using procedures approved
under COMAR
10.10.09.04B.
(9) "Certified chemical
analyst" means an individual who:
(a) Meets
the qualifications established under COMAR
10.10.09.01AA and
.02B; and
(b) Is thereby permitted
to identify marijuana or marijuana products, or both, cocaine base, cocaine
hydrochloride, and heroin using procedures approved under COMAR
10.10.09.04A.
(10) "Certified
chemist" means an individual who:
(a) Meets
the qualifications established under COMAR
10.10.09.01AA and
.02A; and
(b) Is thereby permitted
to identify any controlled dangerous substance using procedures approved under
COMAR 10.10.09.04A.
(11) "CFR" means the
Code of Federal Regulations.
(12)
"CLIA" means the federal Clinical Laboratory Improvement Amendments of 1988 in
Section 353 of the Public Health Service Act and any amendments to it
(42 U.S.C. § 263a).
(13) "CMS" means the federal Centers for
Medicare and Medicaid Services.
(14) "Collection station" means a site other
than a laboratory where specimens are gathered before being shipped elsewhere
for laboratory testing.
(15)
"Complaint investigation" means an investigation of a laboratory, including an
on-site survey, initiated in response to a complaint.
(16) "Control sample" means a material,
solution, or lyophilized preparation used in laboratory quality control, the
concentration of which is within certain specified and known limits.
(17) "Controlled dangerous substance" means
any drug, substance, or immediate precursor in Schedules I through V of
Criminal Law Article, Title 5, Subtitle 4, Annotated Code of
Maryland.
(18) "Deficiency" means a
situation or finding of statutory or regulatory noncompliance.
(19) "Department" means the Department of
Health and Mental Hygiene.
(20)
"Directed plan of correction" means a set of corrective actions stipulated by
the Secretary that a laboratory shall implement to effect statutory or
regulatory compliance.
(21)
Discipline.
(a) "Discipline" means a
scientific field of study in which a laboratory is licensed to offer to perform
or perform tests.
(b) "Discipline"
includes:
(i) Chemistry, including the
subdisciplines of blood gas analysis, endocrinology, radioimmunoassay, routine
chemistry, toxicology, and urinalysis;
(ii) Forensic toxicology, including
job-related alcohol and controlled dangerous substances, limited to the
detection of alcohol or a controlled dangerous substance for a non-therapeutic
or non-diagnostic, job-related purpose.
(iii) Genetics, including the subdisciplines
of biochemical genetics, cytogenetics, medical genetics, and molecular
genetics;
(iv) Health awareness
testing, which is limited to health awareness tests set forth in §B(27) of
this regulation;
(v) Hematology,
including the subdisciplines of coagulation testing, hemoglobinopathy
screening, and routine hematology;
(vi) Immunology, including the subdisciplines
of serology, immunohematology, and histocompatibility;
(vii) Microbiology, including the
subdisciplines of bacteriology, mycobacteriology, mycology, parasitology, and
virology;
(viii) Molecular biology,
including nucleic acid probes; nucleic acid target, probe, and signal
amplifications; recombinant nucleic acid techniques; and other techniques of
applied molecular genetics other than cytogenetics used in connection with the
diagnosis and control of human disease or the assessment of human health;
and
(ix) Pathology, including the
subdisciplines of gynecologic cytology, dermatopathology, and
histopathology.
(22) "Examinee" means an individual:
(a) Whose specimen is collected or tested by
a laboratory; or
(b) Who is subject
to a proficiency test in gynecologic cytology.
(23) "Excepted laboratory" means a medical
laboratory that offers to perform or performs tests limited to one or more
excepted tests.
(24) "Excepted
test" means a medical laboratory test, as set forth in COMAR
10.10.03.02B,
that is authorized by the Secretary to be offered or performed by a laboratory
operating under a letter of exception.
(25) "Exfoliative" means falling off in
scales or layers.
(26) General
Supervisor.
(a) "General supervisor" means a
technologist who possesses at least 4 years technical experience in a licensed
medical laboratory other than an excepted laboratory.
(b) "General supervisor" includes an
individual who qualified as a supervisory technologist under previous State
regulations.
(27)
"HDL-C" means high density lipoprotein cholesterol.
(28) Health Awareness Test.
(a) "Health awareness test" means a test
approved by the Secretary to be performed at a temporary or mobile laboratory,
such as a health fair in a shopping mall.
(b) "Health awareness test" is limited to
tests that:
(i) Are performed solely for the
purposes of screening for certain medical conditions and are not to be used for
diagnostic or management of healthcare conditions;
(ii) Are performed on a CLIA waived testing
device; and
(iii) Measure glucose,
lipids, or other clinical values which the Secretary has concluded are in the
interest of public health to be measured at a health awareness event.
(29) "Immediate
jeopardy" means a deficiency that poses immediate danger to public health or
safety and requires the Secretary to take immediate action to remove the
jeopardy.
(30) "Immediate
precursor" means a substance that the Department has found to be, and by
regulation designates as being, the principal compound commonly used or
produced primarily for use and that is an immediate chemical intermediary used
or likely to be used in the manufacture of a controlled dangerous substance,
the control of which is necessary to prevent, curtail, or limit that
manufacture.
(31) "Laboratory"
means a medical laboratory.
(32)
"Letter of exception" means a license issued by the Secretary authorizing the
operation of a laboratory to offer to perform or perform one or more excepted
tests.
(33) "Letter of
exception-limited testing for rare diseases" means a license issued by the
Secretary authorizing the operation of a laboratory to offer to perform or
perform testing limited to one or more rare disease tests.
(34) "License" means a permit, letter of
exception, certificate, or other document issued by the Secretary granting
approval or authority to:
(a) Offer to perform
or perform medical laboratory tests or examinations in this State;
(b) Offer to perform or perform medical
laboratory tests or examinations on specimens acquired from health care
providers in this State at a medical laboratory located outside this State;
or
(c) Represent or service in this
State a medical laboratory regardless of the laboratory's location.
(35) "Licensed laboratory" means a
laboratory operating under a license issued by the Secretary.
(36) "Licensee" means a person who holds a
license under this chapter to operate a laboratory.
(37) "Limited public health testing" means
testing limited to a combination of 15 or fewer excepted tests performed by a
nonprofit organization or a State, county, or local health
department.
(38) "Marginal
proficiency testing performance" means failure to attain the minimum
satisfactory score for two of three consecutive proficiency testing
events.
(39) Medical Laboratory.
(a) "Medical laboratory" means a facility,
entity, or site that offers to perform or performs tests in connection with:
(i) The diagnosis and control of human
disease;
(ii) The assessment of
human health, nutrition, or medical conditions; or
(iii) Job-related testing.
(b) "Medical laboratory" includes
but is not limited to a:
(i) Physician office
laboratory;
(ii) Point-of-care
laboratory;
(iii) Laboratory owned
or operated by the State, a county, or a municipal health department;
(iv) Not-for-profit laboratory;
(v) Hospital laboratory; and
(vi) Commercial laboratory.
(40) Method
Verification.
(a) "Method verification" means
evaluation of an analytical system by assessment of each analytical system
component, including instrument, test strip, cartridge, card, and kit
reagent.
(b) "Method verification"
includes but is not limited to the determination of:
(i) An analytical system's reportable
range;
(ii) Accuracy; and
(iii) Within-run and run-to-run
precision.
(41) "Mobile laboratory" means a laboratory
located in a moveable vehicle, such as a truck, trailer, van, or
ambulance.
(42) "Multi-site permit"
means a permit available to the State, a county, or a municipal health
department authorizing the operation of limited public health testing at more
than one mobile or permanent laboratory.
(43) "Office of Health Care Quality (OHCQ)"
means the Office of Health Care Quality of the Department of Health and Mental
Hygiene, formerly the Licensing and Certification Administration
(LCA).
(44) "Operator of an
analytical system" means an individual who applies a test specimen or control
sample to an analytical system and performs the necessary operative steps to
isolate or identify an infectious agent or measure an analyte.
(45) "Owner" means a person who possesses a
financial interest in a laboratory.
(46) "Patient of the practice" means an
individual who accepts referral to or is seen or otherwise examined by a member
or members of a practice of medicine.
(47) Permit.
(a) "Permit" means a license issued by the
Secretary authorizing a person to operate a medical laboratory conducting one
or more tests that are not excepted tests.
(b) "Permit" includes a:
(i) Provisional permit; and
(ii) Temporary permit.
(48) "Permitted laboratory" means
a licensed laboratory operating under a permit.
(49) "Phlebotomist" means an individual who
procures a blood specimen by venipuncture, arterial puncture, or capillary
sampling.
(50) "Physician" means a
doctor of medicine or a doctor of osteopathy licensed by the Maryland State
Board of Physicians and a doctor of podiatric medicine licensed by the Maryland
State Board of Podiatric Medical Examiners.
(51) "Physician of a practice" means a
physician employed, salaried, or otherwise engaged to operate or function as a
member in a medical practice, even if the physician does not have an ownership
interest in the practice or the practice's laboratory.
(52) "Physician office laboratory (POL)"
means a medical laboratory operated by a single practice of medicine,
individually or collectively by one or more physicians, that is used solely as
an adjunct to the care of patients of the practice.
(53) "Point-of-care laboratory (POCL)" means
a laboratory operated as part of, or in association with, a medical care
facility, such as a hospital, nursing home, community health center, health
maintenance organization, county or municipal health department, or a
pharmacy.
(54) "Practice" means:
(a) An individual physician licensed to
practice medicine in the State; or
(b) A medical partnership, professional
association, professional service corporation, or medical corporation of two or
more physicians licensed to practice medicine in the State and sharing
facilities, personnel, income, or business expenses.
(55) "Precision" means the agreement of
results among themselves when a specimen or sample is tested multiple
times.
(56) "Pre-field evaluation"
means the assessment of an analytical system before it may be used in a mobile
or temporary laboratory.
(57)
"Primary standard" means a comprehensive general standard or set of standards
that:
(a) A laboratory must meet to obtain or
retain a license to operate; or
(b)
An individual must meet in order to examine gynecologic cytology
specimens.
(58)
"Principal sanction" means the denial, suspension, or revocation of a
license.
(59) "Proficiency testing
(PT)" means evaluation of an individual's ability to perform laboratory
procedures or tests within the PT program's defined limits of accuracy through
analysis of unknown samples distributed at periodic intervals by an external
source.
(60) "Public health
laboratory" means a public, nonprofit laboratory solely owned and operated by
or for the State, a county, or a municipal health department located in the
State.
(61) Quality Assurance.
(a) "Quality assurance" means a system of
established written policies and procedures designed to monitor, review,
evaluate, and improve the ongoing and overall quality of the preanalytic,
analytic, and postanalytic aspects of laboratory testing.
(b) "Quality assurance" includes but is not
limited to practices involving:
(i) Patient
preparation;
(ii) Specimen
collection, labeling, processing, and transport;
(iii) Quality control strategies, practices,
and results;
(iv) Record
keeping;
(v) Personnel training and
competency;
(vi) Continuing
education;
(vii) Proficiency
testing;
(viii) Remedial and
corrective actions; and
(ix)
Analytical system evaluation, validation, and verification.
(62) Quality Control.
(a) "Quality control" means established
written policies and procedures designed to ensure reliable laboratory testing
by monitoring, reviewing, and evaluating the analytic aspects of laboratory
testing.
(b) "Quality control"
includes but is not limited to policies and procedures that detect, monitor,
review, and evaluate the:
(i) Accuracy and
precision of the analytic phase of a testing process;
(ii) Changes in the chemical, electronic,
optical, or mechanical components of an analytical system;
(iii) Deterioration of reagents, materials,
or supplies used in a testing process; and
(iv) Personnel practices during a testing
process.
(63)
"Quality control test" means an examination performed on an external test
sample that:
(a) Is not part of the analytical
system;
(b) Contains a known
quantity of the analyte being tested;
(c) Is similar in its physical
characteristics and constituents to patient specimens tested by the system;
and
(d) Reacts with all system
components in the same way as a patient specimen.
(64) "Rare disease" means:
(a) A disabling, chronically debilitating, or
life-threatening disease or condition that has fewer than 200,000 affected
individuals in the United States, which is equivalent to:
(i) A prevalence of fewer than one individual
per 2,000 individuals in the population; or
(ii) An incidence of fewer than one affected
individual per 10,000 individuals in the population;
(b) A disabling or life-threatening disease
or condition that is listed as a rare disease by the National Institutes of
Health Office of Rare Diseases; or
(c) A disabling or life-threatening disease
or condition in which more than 200,000 individuals are affected if:
(i) A subpopulation of the disease or
condition is equal to the prevalence standard for a rare disease in
§B(64)(a) of this regulation; or
(ii) The incidence of the disease or
condition is fewer than five affected individuals per 10,000 in a defined
community.
(65) Rare Disease Test.
(a) "Rare disease test" means a test that is:
(i) Performed on a specimen obtained from an
individual in order to determine or evaluate whether the individual has a rare
disease or condition;
(ii) Based on
a single method using one sample of a specimen to produce the test result;
and
(iii) Not routinely offered or
performed by a medical laboratory permitted by the Department.
(b) "Rare disease test" includes a
test with multiple clinical or health evaluation uses such as:
(i) Newborn screening;
(ii) Carrier screening;
(iii) Predictive testing;
(iv) Disease diagnosis; or
(v) Disease prognosis.
(66) "Reliable" means that the
quality of a test result meets the quality standards for the preanalytic,
analytic, and postanalytic phases of the testing process as set forth in COMAR
10.10.06.
(67) "Remeasurement"
means repeating the measurement of an analyte.
(68) "Sample" means a substance, constituent,
or material intended for use in quality control, proficiency testing, or
another aspect of a laboratory's quality assurance program.
(69) Sanction.
(a) "Sanction" means an action that the
Secretary may take to effect statutory or regulatory compliance.
(b) "Sanction" includes a principal sanction
and an alternative sanction.
(70) Secretary.
(a) "Secretary" means the Secretary of Health
and Mental Hygiene or the Secretary's designee.
(b) "Secretary" includes the Office of Health
Care Quality as a designee.
(71) "Single-use test device for forensic
testing" means the reagent-containing unit of a test system that:
(a) Is in the form of a sealed container or
cartridge possessing a validity check;
(b) Possesses a nonresealable closure or an
evidentiary tape to ensure detection of tampering;
(c) Is self-contained and individually
packaged;
(d) Is discarded after
each test; and
(e) Does not allow
any test component or constituent of a test system to interact from test to
test.
(72) "Single-use
test device for nonforensic testing" means the reagent-containing unit of a
test system in the form of a cartridge, test pack, or other container that:
(a) Includes a validity check;
(b) Is self-contained and individually
packaged;
(c) Is discarded after
each test; and
(d) Does not allow
any test component or constituent of a test system to interact from test to
test.
(73) "SOPM" means
a standard operating procedure manual.
(74) "Specialty" means a scientific field of
study within a laboratory subdiscipline, such as compatibility testing within
the subdiscipline of immunohematology.
(75) "Specimen" means material collected from
the human body and intended for laboratory testing.
(76) "Standard" means one or more specific
technical, procedural, fiscal, or other requirements that a laboratory or
individual must meet to comply with this chapter.
(77) "Subdiscipline" means a scientific field
of study within a laboratory discipline, such as bacteriology within the
discipline of microbiology and dermatopathology within the discipline of
pathology.
(78) Survey.
(a) "Survey" means an on-site visit to a
laboratory by one or more employees of the OHCQ to carry out or oversee the
regulation of medical laboratories.
(b) "Survey" includes but is not limited to:
(i) Inspection;
(ii) Follow-up inspection;
(iii) Complaint investigation; and
(iv) On-site monitoring.
(79) System Check.
(a) "System check" means a device that
verifies all or part of the chemical, electronic, optical, or mechanical
components or constituents of a test system to determine if the test system is
functioning properly.
(b) "System
check" includes chemical, electronic, optical, or mechanical devices, such as a
card, tube, or strip that simulates a properly functioning single-use test
device.
(c) "System check" does not
include a quality control test sample or patient specimen.
(80) "Technical supervisor" means an
individual who is qualified to direct medical laboratory testing in at least
one laboratory discipline.
(81)
"Technician" means an individual who has at least 1 year of experience in a
licensed medical laboratory, other than an excepted laboratory, and who has
earned:
(a) An associate degree in a
laboratory science or medical laboratory technology from an accredited college
or university; or
(b) 60 semester
hours of academic credit, including 24 semester credit hours of science that
include:
(i) 6 semester hours of chemistry,
and
(ii) 6 semester hours of
biology.
(82)
"Technologist" means an individual who:
(a)
Possesses a bachelor's degree in a chemical, physical, biological, or clinical
laboratory science or in medical technology from an accredited college or
university and has at least 1 year of full-time laboratory experience in the
discipline in which the individual performs tests;
(b) Received a passing score in the United
States Department of Health and Human Services proficiency examination for
clinical laboratory technologists; or
(c) Meets the technologist qualifications set
forth in 42 CFR § 493.1491, which is incorporated by reference
in Regulation .04 of this chapter.
(83) "Temporary laboratory" means a medical
laboratory located at a temporary testing site, such as a health fair or
shopping mall, for fewer than 30 days in 12 consecutive months.
(84) "Test" means a medical laboratory
examination, analysis, procedure, or preanalytic, analytic, or postanalytic
phase of a testing process.
(85)
"Testing event" means an occasion when a health awareness test is offered or
performed on a specified date at a temporary laboratory.
(86) "Testing personnel" means an individual
or individuals employed or otherwise engaged by a laboratory to perform medical
laboratory tests.
(87) "Total
number of tests" means all tests performed by a laboratory in all disciplines
in the previous calendar year.
(88)
"Unsatisfactory proficiency testing performance" means failure to attain the
minimum satisfactory score for three of four consecutive proficiency testing
events.
(89) "Validity check" means
a procedural, testing process, or analytical verification of proper performance
of one or more analytical steps performed by the test system operator, built
into a single-use test device, and carried out by a single-use test device to
detect environmental damage or interfering substances that may have affected
the device or the results of the testing process.
Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.